B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

IARS1

MOLECULAR TARGET

isoleucyl-tRNA synthetase 1

UniProt: P41252NCBI Gene: 33761 compounds

IARS1 (isoleucyl-tRNA synthetase 1) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting IARS1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Mupirocin0.691

About IARS1 as a Drug Target

IARS1 (isoleucyl-tRNA synthetase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented IARS1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

IARS1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.